Diagnosing Autoimmune Limbic Encephalitis

Overview

Journal CMAJ

Date 2019 May 16

PMID 31085562

Citations 38

Authors

Adrian Budhram

Andrew Leung

Michael W Nicolle

Jorge G Burneo

Affiliations

Soon will be listed here.

Citing Articles

Microglial Activation Visualized by [F]-DPA714 PET Is a Potential Marker of Severity and Prognosis for Anti-LGI1 Encephalitis.

Wang J, Ge J, Deng B, Lin H, Yang W, Sheng T Eur J Neurol. 2025; 32(3):e70107.

PMID: 40052391 PMC: 11886409. DOI: 10.1111/ene.70107.

Severe anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis with prolonged hyperammonemia: a case report.

Yan C, Bai L, Du J, Chong Z, Xu G, Yang X BMC Neurol. 2025; 25(1):43.

PMID: 39891080 PMC: 11783855. DOI: 10.1186/s12883-025-04040-8.

The role of the adenylate kinase 5 gene in various diseases and cancer.

Siddiqui M, Shahi M, Castresana J J Clin Transl Sci. 2024; 8(1):e96.

PMID: 39655021 PMC: 11626602. DOI: 10.1017/cts.2024.536.

Autoimmune disease: a view of epigenetics and therapeutic targeting.

Mu S, Wang W, Liu Q, Ke N, Li H, Sun F Front Immunol. 2024; 15:1482728.

PMID: 39606248 PMC: 11599216. DOI: 10.3389/fimmu.2024.1482728.

An Unusual Case of Limbic Encephalitis Caused by Whipple Disease.

Miller A, Park J, Penney A, Geraghty J, Lui F Cureus. 2024; 16(7):e65385.

PMID: 39071075 PMC: 11283316. DOI: 10.7759/cureus.65385.

References

Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

Graus F, Delattre J, Antoine J, Dalmau J, Giometto B, Grisold W . Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004; 75(8):1135-40. PMC: 1739186. DOI: 10.1136/jnnp.2003.034447. View

van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer M . The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017; 13(5):290-301. DOI: 10.1038/nrneurol.2017.43. View

Vogrig A, Joubert B, Ducray F, Thomas L, Izquierdo C, Decaestecker K . Glioblastoma as differential diagnosis of autoimmune encephalitis. J Neurol. 2018; 265(3):669-677. DOI: 10.1007/s00415-018-8767-1. View

van Sonderen A, Arino H, Petit-Pedrol M, Leypoldt F, Kortvelyessy P, Wandinger K . The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016; 87(5):521-8. PMC: 4970662. DOI: 10.1212/WNL.0000000000002917. View

Lancaster E . Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2 Neuro-oncology):452-75. PMC: 4443809. DOI: 10.1212/01.CON.0000464180.89580.88. View

Weil A, Glaser C, Amad Z, Forghani B . Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2002; 34(8):1154-7. DOI: 10.1086/339550. View

Dalmau J, Graus F . Antibody-Mediated Encephalitis. N Engl J Med. 2018; 378(9):840-851. DOI: 10.1056/NEJMra1708712. View

Pellkofer H, Kuempfel T, Jacobson L, Vincent A, Derfuss T . Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. J Neurol Neurosurg Psychiatry. 2010; 81(12):1407-8. DOI: 10.1136/jnnp.2009.186494. View

10.

Gultekin S, Rosenfeld M, Voltz R, Eichen J, Posner J, Dalmau J . Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000; 123 ( Pt 7):1481-94. DOI: 10.1093/brain/123.7.1481. View

11.

Titulaer M, Soffietti R, Dalmau J, Gilhus N, Giometto B, Graus F . Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2010; 18(1):19-e3. PMC: 3086523. DOI: 10.1111/j.1468-1331.2010.03220.x. View

12.

Irani S, Michell A, Lang B, Pettingill P, Waters P, Johnson M . Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011; 69(5):892-900. DOI: 10.1002/ana.22307. View

13.

Gresa-Arribas N, Planaguma J, Petit-Pedrol M, Kawachi I, Katada S, Glaser C . Human neurexin-3α antibodies associate with encephalitis and alter synapse development. Neurology. 2016; 86(24):2235-42. PMC: 4909558. DOI: 10.1212/WNL.0000000000002775. View

14.

Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R . Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008; 131(Pt 10):2553-63. DOI: 10.1093/brain/awn183. View

15.

Pittock S, Lucchinetti C, Parisi J, Benarroch E, Mokri B, Stephan C . Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005; 58(1):96-107. DOI: 10.1002/ana.20529. View

16.

Hosoki S, Satoi H, Matsumoto S . Bilateral Hippocampal Infarction Mimicking Limbic Encephalitis. Intern Med. 2017; 57(6):911-912. PMC: 5891540. DOI: 10.2169/internalmedicine.9543-17. View

17.

Li L, Sun L, Du R, Zheng Y, Dai F, Ma Q . Application of the 2016 diagnostic approach for autoimmune encephalitis from Lancet Neurology to Chinese patients. BMC Neurol. 2017; 17(1):195. PMC: 5674240. DOI: 10.1186/s12883-017-0974-3. View

18.

Oyanguren B, Sanchez V, Gonzalez F, de Felipe A, Esteban L, Lopez-Sendon J . Limbic encephalitis: a clinical-radiological comparison between herpetic and autoimmune etiologies. Eur J Neurol. 2013; 20(12):1566-70. DOI: 10.1111/ene.12249. View

19.

Aurangzeb S, Symmonds M, Knight R, Kennett R, Wehner T, Irani S . LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure. 2017; 50:14-17. PMC: 5558811. DOI: 10.1016/j.seizure.2017.05.017. View

20.

Graus F, Escudero D, Oleaga L, Bruna J, Villarejo-Galende A, Ballabriga J . Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol. 2018; 25(8):1011-1016. PMC: 6037545. DOI: 10.1111/ene.13661. View